AIDX
20/20 Biolabs, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$0.47
−1.36%Latest reported
- Last report date
- Aug 7, 2026
- EPS actual
- -$0.26
- EPS estimate
- -$0.12
- Revenue actual
- $730.6K
- Revenue estimate
- $636.0K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 0
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -116.7%
- Revenue beats (12Q)
- 1
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 7, 2026 | -$0.12 | -$0.26 | Miss -116.67% | $730.6K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Aug 7, 2026